Nobody is demonising the non mrna vaccines....just stick to the facts...also what do you mean they are not making money out of it?...since when was the Govt making money out of the vaccination process in the first place?.. In fact it is our tax prayers money which is financing the mrna vaccination process...
Singapore Temasek invests in COVID vaccine testing company
German BioNTech raises $250m from the sovereign wealth fund and others
Singapore state-owned investment company Temasek has targeted multiple biotechnology companies for investments. © Reuters
LESLIE SHAFFER, DealStreetAsiaJune 30, 2020 14:03 JST
SINGAPORE -- Nasdaq-listed BioNTech, which is testing a COVID-19 vaccine candidate, said Monday it has raised $250 million from Singapore state-owned investment company Temasek and other accredited investors in a private placement.
"We are pleased to welcome Temasek on board as a new shareholder. We believe their long-term investment approach, global presence, and deep experience in the biotechnology field are a good fit," Ugur Sahin, the German-based BioNTech's CEO and co-founder, said in a statement.
The placement included around $139 million in ordinary shares and $112 million in four-year mandatory convertible notes, the company said in the statement.
The private placement investors will receive 2.60 million ordinary shares with a 180-day lock-up agreement, while the convertible notes have a 4.5% coupon and a conversion premium of 20% over the reference price, the statement said. The deal is expected to close in August.
BioNTech focuses on patient-specific immunotherapies to treat cancer and infectious diseases; the company is developing multiple mRNA vaccine candidates for infectious diseases.
In May, BioNTech and Pfizer announced they had dosed the first U.S. participants in a phase 1-2 clinical trial for a vaccine to prevent the COVID-19 virus.
Earlier this month, BioNTech signed a 100 million euro ($112 million) debt financing deal with the European Investment Bank in a move to boost its manufacturing capacity to be able to quickly supply the COVID-19 vaccine.
The Singapore state-owned investment company has targeted multiple biotechnology companies for investments this year.
Temasek's other biotechnology health care investments have included KAHR Medical, an Israeli biopharmaceutical company developing a novel drug platform. The $18 million investment in KAHR Medical, which was made in February, was led by Mirae Asset Venture Investment; Temasek invested via Pavilion Capital.
In March, Temasek led a $70 million round in Shanghai-based Abbisko Therapeutics, which is developing novel cancer therapies.
In April, Temasek-backed Vertex Ventures participated in a $170 million investment round in ElevateBio, a U.S.-based cell and gene therapy firm.
In May, Temasek led a $65 million investment round in SQZ Biotechnologies, a U.S.-based clinical-stage cell therapy company which also is expanding into infectious diseases.
For the original story from DealStreetAsia, click here.
https://asia.nikkei.com/Spotlight/D...asek-invests-in-COVID-vaccine-testing-company
Behind the scenes, the island state has been making the smartest bets possible, as early as possible. In June 2020, before Phase III data confirmed the clinical benefit of the Pfizer / BioNTech mRNA vaccine for COVID-19, Singapore’s Temasek Holdings and other investors invested $250 million into BioNTech. Back in 2018, Singapore’s EDBI (investment arm of EDB) invested in Moderna’s last private equity round before the company went public.
https://www.vertexventureshc.com/ne...t-to-become-biontech-s-regional-mrna-partner/